CLDF Title
Home | Contact Us | Bookmark
 
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
CME Dinner Meetings Webcasts Slide Library Abstract Library Conference Highlights
 
Back Regulatory  
 
Available Topics
06-10-2013 FDA wants more safety data on hepatitis B vaccine
03-18-2013 EU expands use of Pegasys to kids with chronic hepatitis C
02-25-2013 FDA rejects Dynavax's adult Hepatitis B vaccine on safety concerns
02-18-2013 US FDA okays everolimus to prevent liver transplant rejection
01-09-2013 FDA seeks more time to review drug for hepatitis C
11-19-2012 FDA expands use of eltrombopag to hepatitis C patients
11-16-2012 FDA panel backs Dynavax's hep B vaccine efficacy, not safety
04-26-2012 Don't mix boceprevir with certain HIV drugs: FDA
03-26-2012 FDA adds diabetes, memory loss warnings to statins
03-16-2012 UK cost body backs J&J's Incivo (telaprevir) for hepatitis C
03-08-2012 HCV drug Victrelis (boceprevir) wins UK cost endorsement
10-25-2011 US advisers recommend diabetics get Hep B vaccine
09-22-2011 EU regulator to review anti-obesity medicines
09-20-2011 Hepatitis C drug Incivo (telaprevir) gets EU nod
05-23-2011 Vertex hepatitis C drug Incivek (telaprevir) wins U.S. approval
05-13-2011 U.S. FDA clears new Merck protease inhibitor for hepatitis C
04-26-2011 US FDA panel backs efficacy of Vertex hepatitis drug
04-25-2011 US FDA sees safety issue with investigational Merck hepatitis drug
03-04-2011 FDA removes liver warning from Gilead drug
01-24-2011 EU agency reviews Sanofi's Multaq, backs Jevtana
01-13-2011 FDA seeks less acetaminophen in prescription drugs
05-26-2010 U.S. warns of liver risk with Glaxo, Roche diet drugs
05-12-2010 Promacta study in liver patients halted
03-24-2010 U.S. FDA OKs drug for hepatic encephalopathy
03-17-2010 WHO, UNICEF suspend use of Shantha Bio's vaccine: report
02-23-2010 US panel backs antibiotic for hepatic encephalopathy
04-28-2009 Pain drugs to carry stronger warnings: U.S. FDA
10-30-2008 Liver risk, death seen with Avandia: group
03-21-2008 EU follows U.S. with Tysabri liver warning
03-13-2008 J&J, FDA warn of liver risk with HIV drug Prezista
12-13-2007 Merck recalls 1.2 mln doses of children's vaccines
11-19-2007 Bayer's Nexavar gets U.S. FDA nod for liver cancer
10-04-2007 Canada pulls Prexige on hepatitis fears
09-21-2007 EU agency backs Bayer's Nexavar for liver cancer
08-13-2007 Australia bans Novartis's Prexige on liver worries
04-06-2007 US FDA clears Cangene's anti-hepatitis B product
03-07-2007 REFILE: Baraclude treatment of HBV may induce HIV resistance
03-01-2007 Baraclude treatment of HBV may induce HIV resistance
09-26-2006 WHO approves new child vaccine
06-28-2006 Commission approves Baraclude for chronic hepatitis B
04-28-2006 BMS' Baraclude and Sanofi Pasteur MSD's RotaTeq set for EU approval
02-22-2006 Britain's NICE backs Roche's Pegasys and Gilead's Hepsera for hepatitis B
02-07-2006 Canada: may be tie between Sanofi's Ketek, liver harm
01-10-2006 J&J recalls some hepatitis blood tests
10-05-2005 EU OKs briefer Schering-Plough hepatitis C therapy
08-15-2005 FDA approves use of Merck hepatitis A vaccine in 1-year-olds
05-16-2005 Roche gets FDA approval for Pegasys in hepatitis B
03-30-2005 Bayer gets FDA nod for hepatitis A blood test
03-30-2005 US FDA clears Bristol-Myers new drug for chronic hepatitis B
03-16-2005 US FDA, Biogen warn over multiple sclerosis drug
03-11-2005 Bristol-Myers hepatitis drug impressive - US panel
03-10-2005 Entecavir effective against hepatitis B
02-03-2005 Roche's Pegasys wins EU approval for HIV patients
02-03-2005 Lilly's Strattera may be associated with liver problems - UK agency
01-19-2005 US FDA warns about risks of Boehringer AIDS drug
01-18-2005 Bayer gets US FDA approval for hepatitis C test
10-06-2004 Roche hepatitis C drugs win fast review for use in HIV patients
07-13-2004 GlaxoSmithKline vaccine information wrong - US FDA
04-22-2004 CPMP lifts ban on Roche's Parkinson's drug Tasmar
10-21-2003 Europe drops liver biopsy for Schering-Plough's PegIntron
10-13-2003 FDA OKs Schering-Plough's Peg-Intron pen injector
08-29-2003 Bristol in talks with Canada over antidepressant
07-18-2003 EU approves label change for Pegasys/Copegus used to treat hepatitis C
 
 
 
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
CME Dinner Meeting
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare
providers only. Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.